Abstract

There is increasing evidence that C-reactive protein (CRP) can mediate inflammatory reactions following the transformation of functionally inert pentameric CRP (pCRP) into its structural isoform pCRP* and into monomeric CRP (mCRP). This conversion can occur on the membranes of apoptotic or activated cells or on extracellular vesicles (EVs) shed from the cell surface. Here, we characterized the association of CRP with EVs in plasma from sepsis patients using flow cytometry, and found highly elevated levels of total EV counts and CRP+ EVs as compared to healthy individuals. We further assessed the ability of PentraSorb CRP, an extracorporeal device for the adsorption of CRP, to deplete free CRP and CRP+ EVs. Treatment of septic plasma with the adsorbent in vitro resulted in almost complete removal of both, free CRP and CRP+ EVs, while total EV counts remained largely unaffected, indicating the detachment of CRP from the EV surface. EVs from septic plasma elicited a release of interleukin-8 from cultured human monocytes, which was significantly reduced by adsorbent treatment prior to EV isolation. Our findings provide evidence that CRP+ EVs exhibit pro-inflammatory characteristics and can contribute to the spreading of inflammation throughout the circulation on top of their pro-coagulant activity.

Highlights

  • There is increasing evidence that C-reactive protein (CRP) can mediate inflammatory reactions following the transformation of functionally inert pentameric CRP into its structural isoform pCRP* and into monomeric CRP

  • The pro-coagulant activity of extracellular vesicles (EVs) is mainly based on their exposure of phosphatidylserine, which catalyzes the assembly of coagulation complexes on the EV ­surface[35]

  • We characterized the interaction of pro-coagulant EVs from sepsis patients with CRP, which, apart from being a marker of inflammation, can actively mediate tissue damage following structural changes from its native, pentameric state into its monomeric form

Read more

Summary

Introduction

There is increasing evidence that C-reactive protein (CRP) can mediate inflammatory reactions following the transformation of functionally inert pentameric CRP (pCRP) into its structural isoform pCRP* and into monomeric CRP (mCRP) This conversion can occur on the membranes of apoptotic or activated cells or on extracellular vesicles (EVs) shed from the cell surface. EVs can support inflammation by increasing cytokine production and cell surface molecule expression on endothelial cells and l­eukocytes[19,20], but can reduce chemotaxis and phagocytic activity of immune ­cells[21] They promote coagulation via the exposure of phosphatidylserine and tissue ­factor[22,23] and can contribute to the development of disseminated intravascular ­coagulation[24]. PCRP* and mCRP exhibit pro-inflammatory c­ haracteristics[8], and CRP is increasingly considered as a contributor to tissue injury in various d­ iseases[5,29]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call